Black Diamond Therapeutics Cash Flow Statement (2018-2021) | BDTX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021
Operating Activities
Net Income -3.05M-3.84M-6.99M-8.15M-9.90M-12.88M-14.15M-17.32M-21.93M-33.77M-34.59M-25.49M
Depreciation and Depletion 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.04M0.12M
Share-based Compensation 0.09M0.19M0.85M2.51M1.88M1.42M2.00M2.47M3.09M4.56M3.01M3.38M
Gains from Investment Securities 0.02M-0.00M0.01M0.03M0.02M0.00M8.25M0.20M5.72M-5.70M-0.10M
Cash from Operations -6.88M-5.00M-5.31M-7.49M-11.32M-13.57M-11.49M-15.77M-24.45M-25.16M-26.48M-24.05M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.40M0.59M0.73M-0.72M-0.61M-0.49M4.00M
Depreciation & Amortization (CF) 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.04M0.12M
Change in Working Capital
Change in Account Payables -0.05M0.32M0.23M0.96M2.39M-3.75M2.89M-0.46M1.99M-0.36M0.63M-0.69M
Change in Accured Expenses -1.71M0.07M2.50M0.93M0.96M2.03M1.56M3.48M2.84M4.52M3.34M-1.98M
Other Working Capital Changes 1.20M-0.89M-0.03M0.75M3.85M-1.14M-0.40M1.13M2.81M0.15M-0.79M-3.89M
Investing Activities
Capital Expenditures 0.01M-0.00M0.01M0.00M0.03M0.01M0.11M0.39M0.81M1.18M0.33M
Change in Acquisitions & Divestments 17.77M73.16M45.04M50.10M39.19M48.50M
Cash from Investing Activities -0.01M0.00M-0.01M-0.00M-279.64M4.60M-6.65M3.47M48.20M35.70M43.24M
Financing Activities
Other financing activities 0.34M1.33M
Cash from Financing Activities -0.07M44.33M83.50M213.84M0.27M0.83M0.48M0.18M0.06M
Additional items
Change in Cash -6.89M-5.07M39.01M76.01M202.53M-293.21M-6.62M-21.59M-20.50M23.22M9.28M19.20M
Free Cash Flow -6.89M-5.00M-5.32M-7.49M-11.32M-13.59M-11.49M-15.88M-24.84M-25.98M-27.66M-24.38M
Net Cash Flow -6.89M-5.07M39.01M76.01M202.53M-293.21M-6.62M-21.59M-20.50M23.22M9.28M19.20M